Drugs / LP-08
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 2 | NCT01393223 Comparator | Jul 2015 → Jun 2018 | interstitial cystitis | Lipella Pharmaceuticals, Inc. | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | LP-08 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01393223 ↗ |
| Route | Other | “4 weekly intravesical administration of LP-08 80mg” NCT01393223 ↗ |